Abstract:Timely treatment of viral myocarditis (VMC), a form of cardiac inflammation caused by viral infections, can reduce the occurrence of dilated cardiomyopathy and sudden death. Our previous study demonstrated the anti-inflammatory and anti-fibrotic effects of KX, a combination of Sophora flavescens alkaloids and Panax quinquefolium saponins, on an autoimmune myocarditis model in vivo. The present study explored the effects of KX on coxsackievirus B3 (CVB3)-induced acute VMC in mice. Mice were randomly divided into four groups: Control, VMC, KX-high (275 mg/kg) and KX-low (138 mg/kg). Mice in the VMC, KX-high and KX-low groups received injections of CVB3 to establish the VMC model, and those in the KX-high and KX-low groups also received KX by gavage (10 ml/kg) 2 h after virus injection until euthanasia was performed on day 7 or 21. Mice in the control group received an equal KX volume of purified water. The levels of lactate dehydrogenase (LDH), creatine kinase-myocardial band (CK-MB), cardiac troponin I (cTn-I), IL-1β, IL-6, TNF-α and high-sensitive C-reactive protein (hs-CRP) in mouse serum was measured using ELISA. Myocardial tissue structure and degree of injury were observed using hematoxylin and eosin staining. Western blotting and reverse transcription-quantitative PCR were performed to detect the expression levels of NF-κB pathway-related mRNA and protein in myocardial tissue. The results showed that the inflammation and myocardial damage levels of the mice in the VMC group were higher at 7 days than those at 21 days. At both 7 and 21 days, KX decreased the serum CK-MB, LDH, cTn-I, IL-6, TNF-α and hs-CRP levels, and inhibited NF-κB pathway-related mRNA and protein expression in the myocardium of mice. These findings indicated that KX may reduce the inflammatory response and attenuate the pathological damage in the acute and subacute phases of CVB3-induced VMC through the NF-κB pathway.

Ethyl Pyruvate Attenuated Coxsackievirus B3-induced Acute Viral Myocarditis by Suppression of HMGB1/RAGE/NF-ΚB Pathway

MG53 protects against Coxsackievirus B3-induced acute viral myocarditis in mice by inhibiting NLRP3 inflammasome-mediated pyroptosis via the NF-κB signaling pathway

Ginkgo biloba extract may alleviate viral myocarditis by suppression of S100A4 and MMP-3.

Inhibition of Calpain Alleviates Apoptosis in Coxsackievirus B3-induced Acute Virus Myocarditis Through Suppressing Endoplasmic Reticulum Stress.

Involvement of Endoplasmic Reticulum Stress-Mediated C/EBP Homologous Protein Activation in Coxsackievirus B3-Induced Acute Viral Myocarditis

Ethyl Pyruvate Reduces Myocardial Ischemia and Reperfusion Injury by Inhibiting High Mobility Group Box 1 Protein in Rats

A combination of Sophora flavescens alkaloids and Panax quinquefolium saponins attenuates coxsackievirus B3‑induced acute myocarditis in mice via NF‑κB signaling

MG-132 Attenuates Cardiac Deterioration of Viral Myocarditis Via AMPK Pathway

Inhibition of Calpain Alleviates Coxsackievirus B3-induced Myocarditis Through Suppressing the Canonical NLRP3 Inflammasome/caspase-1-mediated and Noncanonical Caspase-11-mediated Pyroptosis Pathways

Cathepsin B aggravates coxsackievirus B3-induced myocarditis through activating the inflammasome and promoting pyroptosis

Blockade of Interleukin-17A Protects Against Coxsackievirus B3-induced Myocarditis by Increasing COX-2/PGE2 Production in the Heart.

Pathogenesis of coxsackievirus B3-induced myocarditis: role of macrophage migration inhibitory factor.

Ethyl Pyruvate Inhibits HMGB1 Phosphorylation and Release by Chelating Calcium

Cardiomyocyte-derived HMGB1 Takes a Protective Role in CVB3-induced Viral Myocarditis Via Inhibiting Cardiac Apoptosis.

Green Tea Polyphenol Epigallocatechin-3-gallate–Alleviated Coxsackievirus B3–induced Myocarditis Through Inhibiting Viral Replication but Not Through Inhibiting Inflammatory Responses

Α-Galactosylceramide Protects Mice from Lethal Coxsackievirus B3 Infection and Subsequent Myocarditis.

Astragalus Polysaccharide from Astragalus Melittin Ameliorates Inflammation Via Suppressing the Activation of TLR-4/NF-κB P65 Signal Pathway and Protects Mice from CVB3-induced Virus Myocarditis.

Dpep2 Emerging As a Modulator of Macrophage Inflammation Confers Protection Against CVB3-Induced Viral Myocarditis

Influence of Ethyl Pyruvate Preconditioning on Myocardial Ischemia and Reperfusion Injury and HMGB1 Expression in Rats

The role of blood podoplanin in patients with viral myocarditis

Inhibitor of CD147 Suppresses T Cell Activation and Recruitment in CVB3-Induced Acute Viral Myocarditis